From June 11 to 13, the 12th China (Shanghai) International Fair for Trade in Services (CIFTIS) was successfully held at the Shanghai World Expo Exhibition & Convention Center. Hangzhou NEUREAL Technology Co., Ltd., a national-level Specialized, Refined, Differential, and Innovative "Little Giant" enterprise, was invited to showcase its independently developed BCI+X precision diagnosis and treatment platform for brain disorders. The platform was awarded the "Advanced BCI Project" honor at this year's CIFTIS, establishing the company as a benchmark in clinical translation and large-scale implementation of non-invasive brain-computer interface technology.
As China's first international, comprehensive, service-oriented technology trade fair, CIFTIS has consistently upheld the mission of "innovation-driven development, intellectual property protection, and promotion of technology trade," having been successfully held for twelve consecutive editions. This year's event, themed "Building a New Ecosystem for Technology Trade and Charting a New Chapter for Global Cooperation," focused on cutting-edge technology tracks with four major exhibition areas covering digital intelligence, green technology, marine technology, consumer technology, and health technology. A total of 1,006 companies participated, setting a new record for attendance, including 236 Fortune Global 500 companies, high-tech enterprises, specialized and innovative SMEs, and gazelle companies, along with 15 major debut projects.
During the expo, NEUREAL's innovative achievements received widespread industry acclaim, with sustained high traffic at its booth. The company engaged in in-depth discussions with industry experts, partners, and investment institutions regarding the application of Brain-Computer Interface (BCI) in core clinical scenarios such as neurological rehabilitation, psychiatric care, and cognitive enhancement. Deeply committed to AI healthcare and non-invasive BCI, NEUREAL adheres to a BCI+X core development strategy, building a full-chain technical system encompassing "precise neural signal induction—target localization—dynamic closed-loop intervention." This approach overcomes the limitations of traditional one-way intervention models in rehabilitation, providing precise and intelligent diagnostic and therapeutic solutions for various brain disorders, including stroke, cognitive impairment, Attention Deficit Hyperactivity Disorder (ADHD), depression, and anxiety disorder.
